Ted Goldstein, Biomolecular Engineering Ph.D.
MedBook Director
Co-PI California Kids Cancer Comparison
University of California, Santa Cruz
Dr. Goldstein is part of David Haussler/Josh Stuart's collaboration with NIH's The Cancer Genome Atlas project and the Stand Up 2 Cancer project dream team.
Cancer is just a bug in a cell's program that forks off new processes faster than the immune system can shut them down. My plan is to create a pipeline that uses machine learning and large scale statistical processing of omic data to identify drug targets for the cancer molecular process pathways that allow cancer cells to erroneously run the stem cell genomic programs that give cancer cells an advantage over healthy cells. Then we will be able to shut down those processes and programs and turn cancer from an ultimately lethal disease into a mildly annoying chronic one.
